STEPHANIE HUSTON: Open Payments
NPI 1083963144 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 62 payments from 27 companies in 2025. Trend: 2023 $457 · 2024 $277 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $208 |
| AstraZeneca Pharmaceuticals LP | 8 | $143 |
| PFIZER INC. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Dynavax Technologies Corporation | 2 | $51 |
| Xeris Pharmaceuticals, Inc. | 1 | $50 |
| Novo Nordisk Inc | 2 | $46 |
| Stryker Corporation | 1 | $39 |
Products named: VRAYLAR, REXULTI, XIFAXAN, QULIPTA, CAPLYTA, AIRSUPRA, Heplisav-B, KEVEYIS.
Industry payments across SC — which companies pay providers there.
